Literature DB >> 15783126

Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5).

Carlos G Musso1.   

Abstract

Potassium is removed mainly by diffusion during dialysis. In hemodialysis, potassium removal averages 70-150 mmol per session, and the presence of glucose-free dialysate, sodium profiling, and hyperkalemia, may increase its removal. The most frequent potassium derangement in hemodialysis patients is hyperkalemia. Hemofiltration removes approximately 60 mmol of potassium per treatment. In peritoneal dialysis patients, despite lower potassium removal (about 30-40 mmol/day), hypokalemia is the most frequent electrolyte alteration, probably due to movement of potassium into the cells mediated by insulin, secondary to glucose absorption from the dialysis solution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15783126     DOI: 10.1007/s11255-004-6194-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.

Authors:  H Gao; S Q Lew; J P Bosch
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

Review 2.  Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature.

Authors:  Effie Tziviskou; Carlos Musso; Vincenzo Bellizzi; Mukesh Khandelwal; Tao Wang; Shokoufeh Savaj; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

3.  Continuous ambulatory peritoneal dialysis - 1981.

Authors:  D G Oreopoulos; R Khanna; P Williams; S I Vas
Journal:  Nephron       Date:  1982       Impact factor: 2.847

Review 4.  Treating interdialytic hyperkalemia with fludrocortisone.

Authors:  Louis J Imbriano; John H Durham; John K Maesaka
Journal:  Semin Dial       Date:  2003 Jan-Feb       Impact factor: 3.455

5.  Profound hypokalemia in continuous ambulatory peritoneal dialysis.

Authors:  S G Rostand
Journal:  Arch Intern Med       Date:  1983-02

6.  Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes.

Authors:  R A Ward; R L Wathen; T E Williams; G B Harding
Journal:  Kidney Int       Date:  1987-07       Impact factor: 10.612

  6 in total
  13 in total

Review 1.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-19       Impact factor: 2.370

2.  Comparative evaluation of essential and toxic elements in the blood of kidney failure patients and healthy referents.

Authors:  Abdul Haleem Panhwar; Tasneem Gul Kazi; Hassan Imran Afridi; Salma Aslam Arain; Mariam S Arain; Kapil Dev Brahman; Naeem Ullah; Jamshed Ali; Sadaf Sadia Arain
Journal:  Environ Monit Assess       Date:  2015-01-30       Impact factor: 2.513

3.  Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.

Authors:  Solmaz Assa; Yoran M Hummel; Adriaan A Voors; Johanna Kuipers; Ralf Westerhuis; Paul E de Jong; Casper F M Franssen
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

4.  Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus.

Authors:  Carlos G Musso; Matilde Navarro; Cesar Mombelli; Cora Giordani; Roxana Groppa; B Martinez; Raul De Miguel; Nora Imperiali
Journal:  Int Urol Nephrol       Date:  2012-12-13       Impact factor: 2.370

Review 5.  Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Authors:  Carlos G Musso; Waldo H Belloso; Richard J Glassock
Journal:  World J Nephrol       Date:  2016-01-06

Review 6.  Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature.

Authors:  Carlos G Musso; Konstantina Trigka; Periklis Dousdampanis; Jose Jauregui
Journal:  Int Urol Nephrol       Date:  2014-12-05       Impact factor: 2.370

7.  Hyperkalemia associated to hepatitis in a peritoneal dialysis patient.

Authors:  Carlos G Musso; Karina Luque; Carlos Schreck; Nora Imperiali; Luis Algarnati
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

8.  Removal of urea by electro-oxidation in a miniature dialysis device: a study in awake goats.

Authors:  Maarten Wester; Maaike K van Gelder; Jaap A Joles; Frank Simonis; Diënty H M Hazenbrink; Theo W M van Berkel; Koen R D Vaessen; Walther H Boer; Marianne C Verhaar; Karin G F Gerritsen
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-11

9.  Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids.

Authors:  Luca Gabutti; Igor Salvadé; Barbara Lucchini; Davide Soldini; Michel Burnier
Journal:  BMC Nephrol       Date:  2011-04-06       Impact factor: 2.388

10.  Time-averaged serum potassium levels and its fluctuation associate with 5-year survival of peritoneal dialysis patients: two-center based study.

Authors:  Shen-Heng Li; Jian-Teng Xie; Hai-Bo Long; Jun Zhang; Wei-Dong Zhou; Hong-Xin Niu; Xun Tang; Zhong-Lin Feng; Zhi-Ming Ye; Yang-Yang Zuo; Lei Fu; Feng Wen; Li-Ping Wang; Wen-Jian Wang; Wei Shi
Journal:  Sci Rep       Date:  2015-10-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.